1887

Abstract

Human coronavirus 229E (HCoV-229E) is responsible for common colds. Like other coronaviruses, HCoV-229E exploits cellular proteases to activate fusion mediated by the spike protein. We analysed the proteolytic processing of the HCoV-229E spike protein by trypsin-like serine proteases leading to activation of the fusion process. Unlike in other coronaviruses, HCoV-229E fusion activation appears to be a one-step process. Indeed, cleavage of the S1/S2 interface does not seem to be a prerequisite, and the fusion activation is highly reliant on the S2′ region, with arginine residue 683 acting as the recognition site.

Keyword(s): entry , fusion , HCoV-229E and spike protein
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001074
2018-07-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/99/7/908.html?itemId=/content/journal/jgv/10.1099/jgv.0.001074&mimeType=html&fmt=ahah

References

  1. Simmons G, Zmora P, Gierer S, Heurich A, Pöhlmann S. Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research. Antiviral Res 2013; 100:605–614 [View Article][PubMed]
    [Google Scholar]
  2. Belouzard S, Chu VC, Whittaker GR. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc Natl Acad Sci USA 2009; 106:5871–5876 [View Article][PubMed]
    [Google Scholar]
  3. Madu IG, Roth SL, Belouzard S, Whittaker GR. Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide. J Virol 2009; 83:7411–7421 [View Article][PubMed]
    [Google Scholar]
  4. Belouzard S, Madu I, Whittaker GR. Elastase-mediated activation of the severe acute respiratory syndrome coronavirus spike protein at discrete sites within the S2 domain. J Biol Chem 2010; 285:22758–22763 [View Article][PubMed]
    [Google Scholar]
  5. Burkard C, Verheije MH, Wicht O, van Kasteren SI, van Kuppeveld FJ et al. Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner. PLoS Pathog 2014; 10:e1004502 [View Article][PubMed]
    [Google Scholar]
  6. Millet JK, Whittaker GR. Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. Proc Natl Acad Sci USA 2014; 111:15214–15219 [View Article][PubMed]
    [Google Scholar]
  7. Hamre D, Procknow JJ. A new virus isolated from the human respiratory tract. Proc Soc Exp Biol Med 1966; 121:190–193 [View Article][PubMed]
    [Google Scholar]
  8. van der Hoek L. Human coronaviruses: what do they cause?. Antivir Ther 2007; 12:651–658[PubMed]
    [Google Scholar]
  9. Kawase M, Shirato K, Matsuyama S, Taguchi F. Protease-mediated entry via the endosome of human coronavirus 229E. J Virol 2009; 83:712–721 [View Article][PubMed]
    [Google Scholar]
  10. Shirato K, Kanou K, Kawase M, Matsuyama S. Clinical isolates of human coronavirus 229E bypass the endosome for cell entry. J Virol 2017; 91:JVI.01387–16 [View Article][PubMed]
    [Google Scholar]
  11. Bertram S, Dijkman R, Habjan M, Heurich A, Gierer S et al. TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium. J Virol 2013; 87:6150–6160 [View Article][PubMed]
    [Google Scholar]
  12. Yamada Y, Liu DX. Proteolytic activation of the spike protein at a novel RRRR/S motif is implicated in furin-dependent entry, syncytium formation, and infectivity of coronavirus infectious bronchitis virus in cultured cells. J Virol 2009; 83:8744–8758 [View Article][PubMed]
    [Google Scholar]
  13. Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL et al. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci USA 2005; 102:11876–11881 [View Article][PubMed]
    [Google Scholar]
  14. Matsuyama S, Ujike M, Morikawa S, Tashiro M, Taguchi F. Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection. Proc Natl Acad Sci USA 2005; 102:12543–12547 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001074
Loading
/content/journal/jgv/10.1099/jgv.0.001074
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error